Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical laboratories SINGAPORE, SG / ACCESS Newswire / March 7, 2026 / Dipylon ...

Based Platforms, Isothermal Amplification Technologies, and Lab-on-a-Chip Systems Accelerating Market Expansion Globally.Austin, United States, March 09, 2026 (GLOBE NEWSWIRE) -- Point-of-Care ...

Janina Krumbeck, PhD, discusses the clinical advantages of next-generation sequencing over traditional culture and how this untargeted diagnostic approach provides comprehensive pathogen ...

Three-site reproducibility study completed by Tampa General Hospital, Mayo Clinic, and Baylor Scott & White HealthSufficient clinical samples ...

When Domain Associates led Xagenic Inc.’s recent $20 million Series B, it marked the eighth diagnostics investment the firm had made with its $500 million eighth fund. The partners say they’ve ...

Wisdom Bioscience, Inc., a biotechnology company pioneering non-invasive oral cancer diagnostics, today announced the formation of its Scientific Advisory Board (SAB) following the close of an initial ...

In the following sections, we highlight ethical concerns about early adoption of molecular diagnostic testing without solid evidence or guidelines and offer practical guidance for ethical ...

Advancing diagnostic precision, integrated therapies, evidence generation, and equitable access are key opportunities to enhance skeletal dysplasia management across global healthcare settings.

Marian Saka is a highly skilled Molecular Genetic Technologist currently working in Texas, bringing extensive expertise in molecular biology, cell biology, immunology, microbiology, and biochemistry.

IMDX is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of IMDX shares has decreased $0.10 since the market last closed. This is a 1.74% ...

Insight Molecular Diagnostics is back in focus after analysts updated their price target, with some now pointing to US$12 alongside a refreshed fair value estimate of US$8.33, previously US$7.00. That ...